Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Thyroid Disease | Research article

Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas

Authors: Dianshuang Xu, Bolin Wu, Xiaoju Li, Yunjiu Cheng, Dubo Chen, Yuefeng Fang, Qiu Du, Zhiyong Chen, Xiaodong Wang

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Acromegaly is highly associated with thyroid disorders. However, the clinical characteristics of thyroid nodules in individuals with acromegaly who present with thyroid diseases have not been completely elucidated.

Methods

Overall, 134 consecutive participants with growth hormone (GH)-secreting adenoma (n = 67) and non-functioning (NF) pituitary adenoma (n = 67) were recruited from the outpatient and inpatient patient department of The First Affiliated Hospital, Jinan University from August 2015 to August 2017. Thyroid ultrasonography was performed using an ultrasound system. The cytopathological results of fine-needle aspiration biopsy were analyzed by a pathologist according to the Bethesda system. Twenty-one patients with GH-secreting adenoma and thyroid disease underwent transsphenoidal pituitary adenoma resection and were followed up for 1 year.

Results

The prevalence of thyroid disease increased in the GH-secreting adenoma group compared with that in the NF pituitary adenoma group. The number of hypoechoic, isoechogenic, heterogeneous, and vascular thyroid nodules increased in patients with GH-secreting adenoma plus thyroid disease compared with that in patients with NF pituitary adenoma plus thyroid disease. Finally, we found significant decreases in the morphology of solid nodules and significant increases in the morphology of cystic nodules after surgery compared with those before surgery in the cured group. Moreover, the numbers of heterogeneous and vascular thyroid nodules decreased significantly after surgery compared with those before surgery in the cured group. However, the characteristics of the thyroid nodules did not change after surgery compared with those before surgery in the non-cured group.

Conclusions

The numbers of hypoechoic, isoechoic, heterogeneous, and vascular thyroid nodules increased in patients with GH-secreting adenomas. In these patients, surgery resulted in significant changes from solid to cystic nodules and also reduced the numbers of heterogeneous and vascular thyroid nodules.
Literature
1.
go back to reference Potter BJ, Beauregard C, Serri O. Serum markers of cardiovascular risk in patients with acromegaly before and after six months of treatment with octreotide LAR. Pituitary. 2008;11(1):49–53.PubMedCrossRef Potter BJ, Beauregard C, Serri O. Serum markers of cardiovascular risk in patients with acromegaly before and after six months of treatment with octreotide LAR. Pituitary. 2008;11(1):49–53.PubMedCrossRef
2.
go back to reference Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102–52.PubMedCrossRef Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102–52.PubMedCrossRef
3.
go back to reference Siegel G, Tomer Y. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Endocr Res. 2005;31(1):51–8.PubMedCrossRef Siegel G, Tomer Y. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Endocr Res. 2005;31(1):51–8.PubMedCrossRef
4.
go back to reference Marchisotti FG, Umeda LM, Zach PL, Saldanha MD, First OS, Liberman B. Acromegaly and thyroid disease: prevalence of thyroid cancer. Arq Bras Endocrinol Metabol. 2005;49(5):843–9.PubMedCrossRef Marchisotti FG, Umeda LM, Zach PL, Saldanha MD, First OS, Liberman B. Acromegaly and thyroid disease: prevalence of thyroid cancer. Arq Bras Endocrinol Metabol. 2005;49(5):843–9.PubMedCrossRef
5.
go back to reference Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, Lowenstein A. Thyroid nodules in acromegaly. Arq Bras Endocrinol Metabol. 2012;56(5):300–4.PubMedCrossRef Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, Lowenstein A. Thyroid nodules in acromegaly. Arq Bras Endocrinol Metabol. 2012;56(5):300–4.PubMedCrossRef
6.
go back to reference Golkowski F, Krzentowska-Korek A, Baldys-Waligorska A, Hubalewska-Dydejczyk A. Goiter, cardiovascular and metabolic disorders in patients with acromegaly. Endocr Regul. 2011;45(4):191–7.PubMedCrossRef Golkowski F, Krzentowska-Korek A, Baldys-Waligorska A, Hubalewska-Dydejczyk A. Goiter, cardiovascular and metabolic disorders in patients with acromegaly. Endocr Regul. 2011;45(4):191–7.PubMedCrossRef
7.
go back to reference Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, et al. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Investig. 2002;25(3):240–5.CrossRef Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, et al. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Investig. 2002;25(3):240–5.CrossRef
8.
go back to reference Loeper S, Ezzat S. Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord. 2008;9(1):41–58.PubMedCrossRef Loeper S, Ezzat S. Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord. 2008;9(1):41–58.PubMedCrossRef
9.
go back to reference Kurimoto M, Fukuda I, Hizuka N, Takano K. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J. 2008;55(1):67–71.PubMedCrossRef Kurimoto M, Fukuda I, Hizuka N, Takano K. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J. 2008;55(1):67–71.PubMedCrossRef
10.
go back to reference Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, Agosti B, Rosei EA. Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155(1):27–31.PubMedCrossRef Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, Agosti B, Rosei EA. Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155(1):27–31.PubMedCrossRef
11.
go back to reference Chen Z, Hu B, Feng Y, Wang Z, Jiang X, Cheng Y, He D, Zhu D, Xiao Z, Wang H, et al. Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study. Ther Clin Risk Manag. 2019;15:65–72.PubMedCrossRef Chen Z, Hu B, Feng Y, Wang Z, Jiang X, Cheng Y, He D, Zhu D, Xiao Z, Wang H, et al. Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study. Ther Clin Risk Manag. 2019;15:65–72.PubMedCrossRef
12.
go back to reference Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–65.PubMedCrossRef Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–65.PubMedCrossRef
13.
go back to reference Unnikrishnan AG, Agrawal NK, Kumar R, Thazhath SS, Reddy DV, Singh SK. Toxic thyroid adenoma and acromegaly: an unusual association. J Assoc Physicians India. 2003;51:412–3.PubMed Unnikrishnan AG, Agrawal NK, Kumar R, Thazhath SS, Reddy DV, Singh SK. Toxic thyroid adenoma and acromegaly: an unusual association. J Assoc Physicians India. 2003;51:412–3.PubMed
14.
go back to reference van Garderen E, Schalken JA. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. Mol Cell Endocrinol. 2002;197(1–2):153–65.PubMedCrossRef van Garderen E, Schalken JA. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. Mol Cell Endocrinol. 2002;197(1–2):153–65.PubMedCrossRef
15.
go back to reference Cabello G, Wrutniak C. Thyroid hormone and growth: relationships with growth hormone effects and regulation. Reprod Nutr Dev. 1989;29(4):387–402.PubMedCrossRef Cabello G, Wrutniak C. Thyroid hormone and growth: relationships with growth hormone effects and regulation. Reprod Nutr Dev. 1989;29(4):387–402.PubMedCrossRef
16.
go back to reference Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab. 1988;67(5):973–8.PubMedCrossRef Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab. 1988;67(5):973–8.PubMedCrossRef
17.
go back to reference Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol. 1997;46(5):545–9.CrossRef Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol. 1997;46(5):545–9.CrossRef
18.
go back to reference Brzozowska M, Kinalska I, Kretowski A. The level of IGF-1 and TGF-beta-1 in the blood serum and the thyroid size in children with normal ioduria. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):215–20.PubMed Brzozowska M, Kinalska I, Kretowski A. The level of IGF-1 and TGF-beta-1 in the blood serum and the thyroid size in children with normal ioduria. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):215–20.PubMed
19.
go back to reference Bruchim I, Attias Z, Werner H. Targeting the IGF1 axis in cancer proliferation. Expert Opin Ther Targets. 2009;13(10):1179–92.PubMedCrossRef Bruchim I, Attias Z, Werner H. Targeting the IGF1 axis in cancer proliferation. Expert Opin Ther Targets. 2009;13(10):1179–92.PubMedCrossRef
20.
go back to reference Balkany C, Cushing GW. An association between acromegaly and thyroid carcinoma. Thyroid. 1995;5(1):47–50.PubMedCrossRef Balkany C, Cushing GW. An association between acromegaly and thyroid carcinoma. Thyroid. 1995;5(1):47–50.PubMedCrossRef
21.
go back to reference Onoda N, Ohmura E, Tsushima T, Ohba Y, Emoto N, Isozaki O, Sato Y, Shizume K, Demura H. Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line. Eur J Cancer. 1992;28A(11):1904–9.PubMedCrossRef Onoda N, Ohmura E, Tsushima T, Ohba Y, Emoto N, Isozaki O, Sato Y, Shizume K, Demura H. Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line. Eur J Cancer. 1992;28A(11):1904–9.PubMedCrossRef
22.
go back to reference Diehl LA, Garcia V, Bonnema SJ, Hegedus L, Albino CC, Graf H, Latin American Throid S. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. J Clin Endocrinol Metab. 2005;90(1):117–23.PubMedCrossRef Diehl LA, Garcia V, Bonnema SJ, Hegedus L, Albino CC, Graf H, Latin American Throid S. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. J Clin Endocrinol Metab. 2005;90(1):117–23.PubMedCrossRef
23.
go back to reference Dogan S, Atmaca A, Dagdelen S, Erbas B, Erbas T. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine. 2014;45(1):114–21.PubMedCrossRef Dogan S, Atmaca A, Dagdelen S, Erbas B, Erbas T. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine. 2014;45(1):114–21.PubMedCrossRef
24.
go back to reference Gullu BE, Celik O, Gazioglu N, Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary. 2010;13(3):242–8.PubMedCrossRef Gullu BE, Celik O, Gazioglu N, Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary. 2010;13(3):242–8.PubMedCrossRef
25.
go back to reference Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, Degli Uberti EC, Pezzino V. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol. 2005;63(2):161–7.CrossRef Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, Degli Uberti EC, Pezzino V. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol. 2005;63(2):161–7.CrossRef
26.
go back to reference Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control. 2002;13(5):395–400.PubMedCrossRef Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control. 2002;13(5):395–400.PubMedCrossRef
27.
go back to reference Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology. 2008;247(3):762–70.PubMedCrossRef Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology. 2008;247(3):762–70.PubMedCrossRef
28.
go back to reference Curto L, Giovinazzo S, Alibrandi A, Campenni A, Trimarchi F, Cannavo S, Ruggeri RM. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study. Eur J Endocrinol. 2015;172(5):543–52.PubMedCrossRef Curto L, Giovinazzo S, Alibrandi A, Campenni A, Trimarchi F, Cannavo S, Ruggeri RM. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study. Eur J Endocrinol. 2015;172(5):543–52.PubMedCrossRef
29.
go back to reference Kan S, Kizilgul M, Celik B, Beysel S, Caliskan M, Apaydin M, Ucan B, Cakal E. The effect of disease activity on thyroid nodules in patients with acromegaly. Endocr J. 2019. Kan S, Kizilgul M, Celik B, Beysel S, Caliskan M, Apaydin M, Ucan B, Cakal E. The effect of disease activity on thyroid nodules in patients with acromegaly. Endocr J. 2019.
Metadata
Title
Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas
Authors
Dianshuang Xu
Bolin Wu
Xiaoju Li
Yunjiu Cheng
Dubo Chen
Yuefeng Fang
Qiu Du
Zhiyong Chen
Xiaodong Wang
Publication date
01-12-2019

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue